NASDAQ
Clearmind Medicine Inc. (CMND) has a free cash flow growth of -15.62% as of Friday, May 29, 2026. This represents a 151.79% decrease compared to its 12-month average of -6.20%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.